| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5846817 | Toxicology and Applied Pharmacology | 2011 | 9 Pages |
Abstract
⺠Characterizes a mouse model of arsenic enhanced NAFLD. ⺠Arsenic synergistically enhances experimental fatty liver disease at concentrations that cause no overt hepatotoxicity alone. ⺠This effect is associated with increased inflammation.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Min Tan, Robin H. Schmidt, Juliane I. Beier, Walter H. Watson, Hai Zhong, J. Christopher States, Gavin E. Arteel,